This mechanical strain on intercostal muscles and ribs can produce localized tenderness and discomfort that feels chest-centered but resolves as nausea symptoms improve
Communicate with your healthcare team
The FDA approved higher-dose oral semaglutide (Rybelsus formulation) for chronic weight management in early 2026
doi:10.1210/jc.2011-1703 Nauck MA, Meier JJ
Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
This boost in energy not only supports daily activities but also enhances the motivation to maintain an active lifestyle, contributing to more effective and sustained weight loss
